Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Chemcon Speciality Chemicals Limited (CHEMCON.NS)
Vadodara, IN
Founded in 1988 and headquartered in Vadodara, India, Chemcon Speciality Chemicals Limited is a producer and vendor of a diverse range of chemical products. The company primarily focuses on manufacturing pharmaceutical intermediates, silanes, and chemicals essential for the oilfield industry, serving both the Indian market and global clients. Its product offerings include a variety of oilfield chemicals such as calcium bromide (liquid and powder forms), sodium bromide solution, and zinc bromide solution. For the pharmaceutical sector, Chemcon supplies key intermediates like hexamethyl disilazane, chloromethyl isopropyl carbonate, trimethyl chlorosilane, and hexamethyl disiloxane, with several of these compounds also categorized under its silanes segment. In addition to production, the company provides contract manufacturing services. Chemcon boasts a significant international presence, exporting its specialty chemicals to a wide array of nations including the United States, Italy, South Korea, Germany, China, Japan, the United Arab Emirates, Serbia, Russia, Spain, Thailand, and Malaysia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.29% | +12.88% | +16.85% | +12.84% | -14.19% | -9.18% | -6.05% | -36.40% | -57.82% | -68.42% | -68.42% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+15.7% ★ Q1'26: +37.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-3.6% Q1'26: +61.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+11.6% Q1'26: +37.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+7.8% Q1'26: +7.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.1% Q1'26: +4.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.76× ★ Q1'26: 1.49× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.43B
est: 2.44B (-0.1%)
|
2.57B
est: 2.57B (-0.1%)
|
3.01B
est: 3.08B (-2.1%)
|
2.67B
est: 3.75B (-28.7%)
|
2.07B
est: 2.07B (+0.0%)
|
2.44B
2.44B – 2.44B
+17.4% YoY
|
2.57B
2.57B – 2.57B
+5.6% YoY
|
3.08B
3.08B – 3.08B
+19.6% YoY
|
3.75B
3.75B – 3.75B
+21.8% YoY
|
| EBITDA |
852.15M
est: 628.94M (+35.5%)
|
908.34M
est: 664.07M (+36.8%)
|
840.11M
est: 794.50M (+5.7%)
|
400.64M
est: 967.82M (-58.6%)
|
328.58M
est: 535.70M (-38.7%)
|
519.55M
519.55M – 519.55M
-3.0% YoY
|
548.56M
548.56M – 548.56M
+5.6% YoY
|
656.31M
656.31M – 656.31M
+19.6% YoY
|
799.48M
799.48M – 799.48M
+21.8% YoY
|
| EBIT |
791.39M
est: 547.87M (+44.4%)
|
845.36M
est: 578.47M (+46.1%)
|
755.85M
est: 692.09M (+9.2%)
|
297.13M
est: 843.06M (-64.8%)
|
223.46M
est: 466.65M (-52.1%)
|
427.20M
427.20M – 427.20M
-8.5% YoY
|
451.06M
451.06M – 451.06M
+5.6% YoY
|
539.65M
539.65M – 539.65M
+19.6% YoY
|
657.37M
657.37M – 657.37M
+21.8% YoY
|
| Net Income |
563.98M
est: 563.72M (+0.0%)
|
627.57M
est: 625.95M (+0.3%)
|
551.10M
est: 585.31M (-5.8%)
|
191.93M
est: 763.95M (-74.9%)
|
244.52M
|
564.30M
564.30M – 564.30M
|
626.60M
626.60M – 626.60M
+11.0% YoY
|
585.92M
585.92M – 585.92M
-6.5% YoY
|
764.74M
764.74M – 764.74M
+30.5% YoY
|
| SGA |
104.88M
est: 152.17M (-31.1%)
|
146.88M
est: 160.67M (-8.6%)
|
147.34M
est: 192.23M (-23.4%)
|
185.16M
est: 234.17M (-20.9%)
|
194.77M
est: 129.61M (+50.3%)
|
199.88M
199.88M – 199.88M
+54.2% YoY
|
211.05M
211.05M – 211.05M
+5.6% YoY
|
252.50M
252.50M – 252.50M
+19.6% YoY
|
307.58M
307.58M – 307.58M
+21.8% YoY
|
| EPS |
16.48
est: 15.40 (+7.0%)
|
17.13
est: 17.10 (+0.2%)
|
15.04
est: 15.99 (-5.9%)
|
5.24
est: 20.87 (-74.9%)
|
6.68
|
15.40
15.40 – 15.40
|
17.10
17.10 – 17.10
+11.0% YoY
|
15.99
15.99 – 15.99
-6.5% YoY
|
20.87
20.87 – 20.87
+30.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kamalkumar Rajendra Aggarwal | Chairman & MD | 12M | male |
| Nareshkumar Vijaykumar Goyal | Joint MD & Director | 6M | male |
| Navdeep Nareshkumar Goyal | Whole-time Director | 6M | male |
| Rajesh Chimanlal Gandhi | Chief Financial Officer, Director of F&A and Whole-time Director | 5M | male |
| Himanshu Prafulchandra Purohit | Director of Production & Whole-time Director | 5M | male |
| Shahilkumar Maheshbhai Kapatel | Company Secretary & Compliance Officer | — | male |
| Ashish Babubhai Luhar | Manager - Production | — | — |
| Chiragkumar Jayantkumar Joshi | Manager - Engineering | — | — |
| Jalpa Maneklal Chauhan | Manager - Marketing | — | — |
| Ajaykumar Harishchandra Mehta | Manager of Purchase | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CHEMCON.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
